INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

COLLEGIUM PHARMACEUTICAL, INC

Filed

February 5, 2025

Period of Report

February 4, 2025

Accession Number

0001062993-25-001753